159
Views
15
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Lipid peroxidation product acrolein as a predictive biomarker of prostate carcinoma relapse after radical surgery

, , , , , , & show all
Pages 497-504 | Received 08 Dec 2009, Published online: 19 Feb 2010

References

  • Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer Statistics, 2008. CA Cancer J Clin 2008;58:71–96.
  • Basu HS, Thompson TA, Church DR, Clower CC, Mehraein-Ghomi F, Amlong CA, Martin CT, Woster PM, Lindstrom MJ, Wilding G. Small molecule polyamine oxidase inhibitor blocks androgen-induced oxidative stress and delays prostate cancer progression in the transgenic adenocarcinoma of the mouse prostate model. Cancer Res 2009;69:7689–7695.
  • Khandrika L, Kumar B, Koul S, Maroni P, Koul HK. Oxidative stress and prostate cancer. Cancer Lett 2009;282:125–136.
  • Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratliff TL. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol 1995;154:407–413.
  • Serkova NJ, Gamito EJ, Jones RH, O’Donnell C, Brown JL, Green S, Sullivan H, Hedlund T, Crawford ED. The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions. Prostate 2008;68:620–628.
  • Dong JT, Rinker-Schaeffer CW, Ichikawa T, Barrett JC, Isaacs JT. Prostate cancer-biology of metastasis and its clinical implications. World J Urol 1996;14:182–189.
  • Carter HB, Piantadosi S, Isaacs JT. Clinical evidence for and implications of the multistep development of prostate cancer. J Urol 1990;143:742–746.
  • Pienta KJ, Esper PS. Risk factors for prostate cancer. Ann Int Med 1993;118:793–803.
  • Ripple MO, Henry WF, Rago RP, Wilding G. Prooxidant–antioxidant shift induced by androgen treatment of human prostate carcinoma cells, J Natl Cancer Inst 1997;89:40–48.
  • Przybyszewski WM, Rzeszowska-Wolny J. Oxidative stress in prostate hypertrophy and carcinogenesis. Postepy Hig Med Dosw 2009;63:340–350.
  • Esterbauer H, Schaur JS, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radic Biol Med 1991;11:81–128.
  • Einhorn IN. Physiological and toxicological aspects of smoke produced during the combustion of polymeric materials. Environ Health Perspect 1975;11:163–189.
  • Johnstone RAW, Plimmer JR. The chemical constituents of tobacco and tobacco smoke. Chem Rev 1959;59:885–936.
  • Izard C, Libermann C. Acrolein. Mutat Res 1978;47:115–138.
  • Anderson MM, Hazen SL, Hsu FF, Heinecke JW. Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsaturated aldehydes by phagocytes at sites of inflammation. J Clin Invest 1997;99:424–432.
  • Beauchamp RO Jr, Andjelkovich DA, Kligerman AD, Morgan KT, Heck HD. A critical review of the literature on acrolein toxicity. Crit Rev Toxicol 1985;14:309–380.
  • Tabor CW, Tabor H, Bachrach U. Identification of the aminoaldehydes produced by the oxidation of spermine and spermidine with purified plasma amine oxidase. J Biol Chem 1964;239:2194–2203.
  • Rudra PK, Krokan HE. Acrolein cytotoxicity and glutathione depletion in n-3 fatty acid sensitive- and resistant human tumor cells. Anticancer Res 1999;19:461–469.
  • Zarkovic K, Uchida K, Kolenc D, Hlupic L, Zarkovic N Tissue distribution of lipid peroxidation product acrolein in human colon carcinogenesis. Free Radic Res 2006;40:543–552.
  • Uchida K, Kanematsu M, Sakai K, Matsuda T, Hattori N, Mizuno Y, Suzuki D, Miyata T, Noguchi N, Niki E, Osawa T. Protein-bound acrolein: Potential markers for oxidative stress (covalent modification of protein/antibody/atherosclerosis). Proc Natl Acad Sci USA Biochem 1998;95:4882–4887.
  • Yilmaz MI, Saglam K, Sonmez A, Gok DE, Basal S, Kilic S, Akay C, Kocar IH. Antioxidant system activation in prostate cancer. Biol Trace Elem Res 2004;98:13–19.
  • Zibzibadze M, Bochorishvili I, Ramishvili L, Managadze L, Kotrikadze N. Investigation of pro- and antioxidative systems’ changes in blood of patients with prostate tumours. Georgian Med News 2009;169:26–29.
  • Iuchi Y, Kaneko T, Matsuki S, Ishi T, Ikeda Y, Uchida K, Fujii J. Carbonyl stress and detoxification ability in the male genital tract and testis of rats. Histochem Cell Biol 2004;121:123–130.
  • Kumar B, Koul S, Khandrika L, Meacham RB, Koul HK. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res 2008;68:1777–1785.
  • Yu YP, Yu G, Tseng G, Cieply K, Nelson J, Defrances M, Zarnegar R, Michalopoulos G, Luo JH. Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. Cancer Res 2007; 67:8043–8050.
  • Sakata K, Kashiwagi K, Sharmin S, Ueda S, Igarashi K. Acrolein produced from polyamines as one of the uraemic toxins. Biochem Soc Trans 2003;31:371–374.
  • Goodwin AC, Jadallah S, Toubaji A, Lecksell K, Hicks JL, Kowalski J, Bova GS, De Marzo AM, Netto GJ, Casero RA Jr. Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissues. Prostate 2008;68:766–772.
  • Babbar N, Casero RA Jr. Tumor necrosis factor-alpha increases reactive oxygen species by inducing spermine oxidase in human lung epithelial cells: a potential mechanism for inflammation induced carcinogenesis. Cancer Res 2006; 66:11125–11130.
  • Xu H, Chaturvedi R, Cheng Y, Bussiere FI, Asim M, Yao MD, Potosky D, Meltzer SJ, Rhee JG, Kim SS, Moss SF, Hacker A, Wang Y, Casero RA Jr, Wilson KT. Spermine oxidation induced by Helicobacter pylori results in apoptosis and DNA damage: implications for gastric carcinogenesis. Cancer Res 2004;64:8521–8525.
  • Yelisyeyeva O, Cherkas A, Zarkovic K, Semen K, Kaminskyy D, Waeg G, Zarkovic N. The distribution of 4-hydroxynonenal-modified proteins in gastric mucosa of duodenal peptic ulcer patients. Free Radic Res 2008;42:205–211.
  • Cherkas A, Yelisyeyeva O, Semen K, Zarkovic K, Kaminskyy D, Cipak A, Jaganjac M, Lutsyk A, Waeg G, Zarkovic N. Persistent accumulation of 4-hydroxynonenal-protein adducts in gastric mucosa after Helicobacter pylori eradication. Coll Antropol 2009;33:315–321.
  • Zarkovic N. 4-Hydroxynonenal as a bioactive marker of pathopysiological processes. Mol Asp Med 2003;24:281–291.
  • Zarkovic N, Ilic Z, Jurin M, Scahur RJ, Puhl H, Esterbauer H. Stimulation of HeLa cell growth by physiological concentrations of 4-hydroxynonenal. Cell Biochem Func 1993;11: 279–286.
  • Zarkovic N, Zarkovic K, Schaur RJ, Stolc S, Schlag G, Redl H, Waeg G, Borovic S, Loncaric I, Juric G, Hlavka V. 4-Hydroxynonenal as a second messenger of free radicals and growth modifying factor. Life Sci 1999;65:1901–1904.
  • Biasi F, Tessitore L, Zanetti D, Citrin JC, Zingaro B, Chiarpotto E, Zarkovic N, Serviddio G, Poli G. Associated changes of lipid peroxidation and TGF-β1 levels in human cancer during tumor progression. Gut 2002;50:361–367.
  • Biasi F, Vizio B, Mascia C, Gaia E, Zarkovic N, Chiarpotto E, Leonarduzzi G, Poli G. JNK up-regulation as a key event in the pro-apoptotic interaction between TGF-β1 and 4-hydroxynonenal in colon mucosa. Free Radic Biol Med 2006;40: 443–454.
  • Marquez-Quiñones A, Cipak A, Zarkovic K, Fattel-Fazenda S, Villa-Treviño S, Zarkovic N, Guéraud F. HNE-protein adducts formation in different pre-carcinogenic stages of hepatitis in LEC rats. Free Radic Res, 2010;44:119–127.
  • Kucuk O, Sarkar FH, Sakr W, Djuric Z, Pollak MN, Khachik F, Li YW, Banerjee M, Grignon D, Bertram JS, Crissman JD, Pontes EJ, Wood DP Jr. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev 2001;10: 861–868.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.